10,827
Total Claims
$1.1M
Drug Cost
1,410
Beneficiaries
$802
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-47%
Cost per patient vs peers
$802 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 9,454 claims · $281K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rivaroxaban | 189 | $215K |
| Apixaban | 184 | $205K |
| Dapagliflozin Propanediol | 128 | $151K |
| Candesartan/Hydrochlorothiazid | 441 | $99K |
| Empagliflozin | 45 | $52K |
| Ticagrelor | 34 | $36K |
| Levothyroxine Sodium | 283 | $36K |
| Sitagliptin Phosphate | 22 | $34K |
| Candesartan Cilexetil | 161 | $27K |
| Sitagliptin Phos/Metformin Hcl | 34 | $25K |
| Metoprolol Succinate | 1,090 | $24K |
| Telmisartan/Hydrochlorothiazid | 125 | $21K |
| Sacubitril/Valsartan | 11 | $21K |
| Nifedipine | 419 | $13K |
| Rosuvastatin Calcium | 668 | $12K |
Prescribing Profile
81
Unique Drugs
$676K
Patient Profile
75
Avg Age
60%
Female
1.95
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About